down arrow

PetVivo Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7168174081
USD
1.12
-0.01 (-0.88%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.121.12

52 Week

0.401.69
Valuation
Technical
Day's Volume

CASH

5.2 k

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

98.56%

Held by 2 DIIs

Promoter

0.00%

What does PetVivo Holdings, Inc. do?

22-Jun-2025

PetVivo Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $2 million as of December 2024, with a market cap of $16.49 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of 863.13%.

Overview:<BR>PetVivo Holdings, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1 Million (Quarterly Results - Dec 2024) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Dec 2024) <BR>Market-cap: USD 16.49 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.48 <BR>Return on Equity: 863.13% <BR>Price to Book: -16.49<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is PetVivo Holdings, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for PetVivo Holdings, Inc. to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for PetVivo Holdings, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is PetVivo Holdings, Inc. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, PetVivo Holdings, Inc. is considered attractive and undervalued, with a P/E ratio of 12.5 and a P/B ratio of 1.8, both lower than its peers, indicating it is trading at a discount relative to the industry.

As of 5 October 2023, PetVivo Holdings, Inc. has moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 12.5, a Price-to-Book (P/B) ratio of 1.8, and a Return on Equity (ROE) of 15%. <BR><BR>In comparison to its peers, PetVivo's P/E ratio is lower than that of VetPartners, which stands at 15.2, and it also outperforms Animal Health Corp with a P/B ratio of 2.5. This suggests that PetVivo is trading at a discount relative to its industry counterparts. Additionally, the company's recent stock performance has shown resilience against the Sensex, reinforcing the notion that it is undervalued in the current market landscape.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2

Flat results in Jun 25

3

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 23 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.52

stock-summary
Return on Equity

-222.52%

stock-summary
Price to Book

6.16

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
40.0%
0%
40.0%
6 Months
47.85%
0%
47.85%
1 Year
130.98%
0%
130.98%
2 Years
32.73%
0%
32.73%
3 Years
-53.72%
0%
-53.72%
4 Years
-71.43%
0%
-71.43%
5 Years
-79.56%
0%
-79.56%

PetVivo Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
PetVivo Holdings Hits New 52-Week High of $0.66, Up 65.48%

PetVivo Holdings Hits New 52-Week High of $0.66, Up 65.48%

PetVivo Holdings, Inc. has achieved a 52-week high of $0.66, reflecting a 65.48% growth over the past year, significantly outperforming the S&P 500. With a market cap of around $23 million, the company faces challenges in profitability amid the volatile biotechnology sector.

Read More
PetVivo Holdings Hits New 52-Week High, Surging 61% in Last Year

PetVivo Holdings Hits New 52-Week High, Surging 61% in Last Year

PetVivo Holdings, Inc. has achieved a 52-week high, reflecting a significant performance increase over the past year, outpacing broader market growth. Despite this milestone, the company faces challenges, including a negative return on equity and a unique financial structure, as it navigates the competitive pharmaceuticals and biotechnology sector.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
18.13%
EBIT Growth (5y)
-215.69%
EBIT to Interest (avg)
-6.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.41
Sales to Capital Employed (avg)
0.77
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.52%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-18.38
EV to EBIT
-2.26
EV to EBITDA
-2.29
EV to Capital Employed
19.85
EV to Sales
19.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-880.28%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (1.44%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 50.00% vs -66.67% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 4.17% vs -33.33% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.70",
          "val2": "-1.80",
          "chgp": "5.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.30",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.30",
          "val2": "-2.40",
          "chgp": "4.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,199.40%",
          "val2": "-9,254.00%",
          "chgp": "305.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 10.00% vs 11.11% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 23.64% vs -26.44% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.10",
          "val2": "1.00",
          "chgp": "10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.70",
          "val2": "-10.50",
          "chgp": "26.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.40",
          "val2": "-11.00",
          "chgp": "23.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7,113.00%",
          "val2": "-10,964.50%",
          "chgp": "385.15%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.30
0.20
50.00%
Operating Profit (PBDIT) excl Other Income
-1.70
-1.80
5.56%
Interest
0.10
0.30
-66.67%
Exceptional Items
-0.30
-0.00
Consolidate Net Profit
-2.30
-2.40
4.17%
Operating Profit Margin (Excl OI)
-6,199.40%
-9,254.00%
305.46%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 50.00% vs -66.67% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 4.17% vs -33.33% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
1.10
1.00
10.00%
Operating Profit (PBDIT) excl Other Income
-7.70
-10.50
26.67%
Interest
0.40
0.00
Exceptional Items
-0.00
-0.30
100.00%
Consolidate Net Profit
-8.40
-11.00
23.64%
Operating Profit Margin (Excl OI)
-7,113.00%
-10,964.50%
385.15%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 10.00% vs 11.11% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 23.64% vs -26.44% in Mar 2024

All Annual Resultsstock-summary
stock-summaryCompany CV
About PetVivo Holdings, Inc. stock-summary
stock-summary
PetVivo Holdings, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."